Log in to save to my catalogue

Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab er...

Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab er...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2560814556

Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era

About this item

Full title

Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era

Publisher

United States: Public Library of Science

Journal title

PloS one, 2021-08, Vol.16 (8), p.e0256024

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Thrombotic thrombocytopenic purpura (TTP) is a diagnostic and therapeutic emergency. Therapeutic plasma exchange (TPE) combined with immunosuppression has been the cornerstone of the initial management. To produce optimal benefits, emerging treatments must be used against a background of best standard of care. Clarifying current uncertainties is th...

Alternative Titles

Full title

Outcomes in 1096 patients with severe thrombotic thrombocytopenic purpura before the Caplacizumab era

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_2560814556

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_2560814556

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0256024

How to access this item